Zimbabwe has declined a significant US health deal valued at 367 million US dollars (£272m) over five years over the United States' demand for confidential information.
This rejection came to light after a official document dated December was leaked, revealing that Head of State Emmerson Mnangagwa believed the agreement was "lopsided".
A government spokesman has since explained that the United States was requesting genetic material for research and commercial purposes but was unwilling to share the benefits from future treatments.
"We are forced to start the challenging and unfortunate process of winding down our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the United States had furnished more than $1.9bn as health assistance to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has urged further talks to reach a agreement suitable to all parties so the country's critical HIV treatment initiative can be sustained.
Wider Background
This rejection follows a comparable case in Kenya, where a high court blocked a similar health funding agreement following legal challenges were raised about the safety of citizens' health data.
Since returning to office last year, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
USAID had managed aid for the American government, but Trump stated its spending was "inefficient" and his administration was pursuing direct bilateral agreements to enhance openness and accountability.
Based on reports, Sixteen nations in Africa have so far signed similar health pacts, representing more than $18.3bn in new funding.
Specifics of the Declined Deal
The funds for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this partnership would have delivered immense benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy through US-supported programmes," Tremont commented.
However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".
"Zimbabwe was being asked to share its biological resources and data for a long time, with no equivalent assurance of access to any scientific breakthroughs – like new medicines or tests – that could result from that provided information," he stated.
"Put simply, our country would supply the basic resources for medical research with no certainty that the end products would be available to our citizens should a new health crisis arise."
National Interest and International Frameworks
He also noted that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were disrupting frameworks already set up through the global organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with future global health emergencies.
"This mechanism is designed to guarantee that when a country contributes its information, the resulting advantages – including medicines and cures – are shared equitably, not monopolised exclusively by those with the resources to create them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We welcome continued discussions with our US partners on how future co-operation could be structured in a manner that respects the independence and interests of each country."
Medical Community Response
A leading public health body stated it understood the official position, but suggested that negotiations need to persist since much of the country's Aids initiatives were funded by external financing.
"Where specific concerns exist, such as those relating to information security or implementation frameworks, these can often be resolved through technical clarification and negotiated safeguards," it commented.
The situation highlights the complex tensions between accepting much-needed international aid and protecting national sovereignty in an ever more interconnected world.